Viewing Study NCT00503594


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2026-01-28 @ 4:59 PM
Study NCT ID: NCT00503594
Status: UNKNOWN
Last Update Posted: 2012-07-30
First Post: 2007-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: P060239
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View